Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Biogen Inc (BIIB) vs Dominion Energy Inc (D) Price & Performance

Biogen IncTrade
Dominion Energy IncTrade

Price performance (Past 24H)

Key statistics

Biogen Inc vs Dominion Energy Inc — how do they compare? Biogen Inc trades at $190.26 (market cap $30.86B), while Dominion Energy Inc trades at $71.2 (market cap $62.27B). The key difference: Dominion Energy Inc is far larger — about 2× Biogen Inc's market cap, and Dominion Energy Inc pays a 3.77% dividend while Biogen Inc pays none. Which is the better fit depends on your goals.

BIIBD
Market Cap
$30.86B$62.27B
Sector
HealthUtilities
52-Week High
$216.63$71.32
52-Week Low
$122.68$56.55
Enterprise Value
$33.14B$114.67B
Dividend Yield
3.77%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Biogen Inc

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021.

Read more on BIIB

About Dominion Energy Inc

Based in Richmond, Virginia, Dominion Energy is an integrated energy company with over 30 gigawatts of electric generation capacity and more than 90,000 miles of electric transmission and distribution lines. Dominion owns a liquefied natural gas export facility in Maryland and is constructing a 5.2 GW wind farm off the Virginia Beach coast.

Read more on D